ARE stock · BEAM stock

ARE vs BEAM · P/E 100, $13.19B cap vs rev $63.5M

Alexandria Real Estate Equities Inc (ARE) versus Beam Therapeutics Inc (BEAM) — a side-by-side from cached financials, not a winner call.

Alexandria Real Estate Equities Inc (ARE) is a reit - office company listed on US.

Beam Therapeutics Inc (BEAM) is a biotechnology company listed on US.

ARE does not have a complete income-statement cache yet.

Latest reported BEAM revenue for 2024-12-31 was $63.5M. Net income was -$376.7M. Revenue was down 83.2% from 2023-12-31 to 2024-12-31. BEAM currently screens at market cap $2.01B.

ARE currently screens at market cap $13.19B and trailing P/E 100.4. BEAM currently screens at market cap $2.01B.

Not investment advice. Open the ARE and BEAM stock pages for the full models.

Not investment advice.

Popular Stock Comparisons